Syros Pharmaceuticals Inc
F:0S90
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Syros Pharmaceuticals Inc
F:0S90
|
US |
|
Fujitsu Ltd
TSE:6702
|
JP |
|
C
|
China Northern Rare Earth Group High-Tech Co Ltd
SSE:600111
|
CN |
|
H
|
Hasbro Inc
XMUN:HAS
|
US |
|
Logan Energy Corp
F:R76
|
CA |
|
S
|
Societe BIC SA
SWB:BIF
|
FR |
|
Roblox Corp
BMV:RBLX
|
US |
|
S
|
Speciality Restaurants Ltd
BSE:534425
|
IN |
|
C
|
Continental AG
XHAM:CON
|
DE |
|
N
|
New York Community Bancorp Inc
F:QC1
|
US |
|
Seco SpA
F:7GV
|
IT |
|
Novacyt SA
F:NYZ
|
FR |
|
Corcept Therapeutics Inc
LSE:0I3Q
|
US |
Bankruptcy Probability
Syros Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Syros Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Syros Pharmaceuticals Inc
NASDAQ:SYRS
|
2.7k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Syros Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Syros Pharmaceuticals Inc has total debt of 41.1m USD. This includes both short-term (0 USD) and long-term (41.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
